Table 1c.
Estimated weekly odds ratios of light use versus heavy use and moderate use versus heavy use for LFD study
Lofex-Dro vs. Placebo | Light vs. Heavy | Moderate vs. Heavy | ||
---|---|---|---|---|
week | OR (95% Cl) | p-value | OR (95% Cl) | p-value |
1 | 1.19 (0.63, 2.25) | 0.5975 | 0.84 (0.43, 1.64) | 0.6044 |
2 | 1.27 (0.76, 2.13) | 0.3575 | 0.99 (0.58, 1.70) | 0.981 |
3 | 1.37 (0.90, 2.07) | 0.1442 | 1.18 (0.76, 1.84) | 0.4666 |
4 | 1.46 (1.01, 2.12) | 0.044 | 1.40 (0.92, 2.14) | 0.1168 |
5 | 1.57 (1.06, 2.32) | 0.0243 | 1.66 (1.03, 2.69) | 0.0371 |
6 | 1.68 (1.05, 2.70) | 0.0311 | 1.98 (1.09, 3.58) | 0.0247 |
7 | 1.80 (1.00, 3.25) | 0.0499 | 2.35 (1.12, 4.93) | 0.024 |
8 | 1.93 (0.94, 3.98) | 0.0745 | 2.79 (1.13, 6.89) | 0.0262 |